Lassen Therapeutics

Lassen Therapeutics

CA - San Diego
Biotechnology
WebsiteLinkedInCareers Page

Focus: Anti-IL-11 Antibodies

Lassen Therapeutics is a life sciences company focused on Anti-IL-11 Antibodies.

Immunology
Funding Stage
SERIES B
Open Jobs
0

Pipeline & Clinical Trials

N/A
Clinical Trials (1)
NCT02290522Copenhagen Prospective Personalized Oncology (CoPPO)
N/A
Phase 1/2
Clinical Trials (1)
NCT05331300A Study to Evaluate the Safety, Preliminary Efficacy, and Pharmacokinetic Properties of LASN01 in Healthy Subjects and in Patients With Pulmonary Fibrosis or Thyroid Eye Disease
Phase 1/2
Phase 2
Clinical Trials (1)
NCT06226545A Study to Evaluate the Efficacy and Safety of LASN01 in Patients With Thyroid Eye Disease
Phase 2
Alectinib
Cancer
Phase 2
Clinical Trials (1)
NCT04341181ProTarget - A Danish Nationwide Clinical Trial on Targeted Cancer Treatment Based on Genomic Profiling
Phase 2
Phase 2
bevacizumab and Irinotecan and radiotherapy
Glioblastoma Multiforme
Phase 2
Clinical Trials (1)
NCT00817284Bevacizumab and Irinotecan or Bevacizumab and Temozolomide With Concomitant Radiotherapy for Primary Glioblastoma Multiforme (GBM)
Phase 2
Phase 2
Clinical Trials (1)
NCT03890952Translational Study of Nivolumab in Combination With Bevacizumab for Recurrent Glioblastoma
Phase 2

Open Jobs (0)

No open positions listed yet. Check their careers page directly.

Interview Prep Quick Facts
Portfolio: 6 clinical trials